Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis

Despite extensive research into the pathophysiology of multiple sclerosis (MS) and recent developments in potent disease-modifying therapies (DMTs), two-thirds of relapsing-remitting MS patients transition to progressive MS (PMS). The main pathogenic mechanism in PMS is represented not by inflammati...

Descripción completa

Detalles Bibliográficos
Autores principales: Maier, Smaranda, Barcutean, Laura, Andone, Sebastian, Manu, Doina, Sarmasan, Emanuela, Bajko, Zoltan, Balasa, Rodica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002756/
https://www.ncbi.nlm.nih.gov/pubmed/36901807
http://dx.doi.org/10.3390/ijms24054375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002756/
https://www.ncbi.nlm.nih.gov/pubmed/36901807
http://dx.doi.org/10.3390/ijms24054375

Ejemplares similares